SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-10-001540
Filing Date
2010-02-26
Accepted
2010-02-26 16:32:40
Documents
10
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2196645z10-k.htm 10-K 1106912
2 EX-10.22 a2196645zex-10_22.htm EX-10.22 12414
3 EX-10.47 a2196645zex-10_47.htm EX-10.47 6634
4 EX-10.48 a2196645zex-10_48.htm EX-10.48 87312
5 EX-23.1 a2196645zex-23_1.htm EX-23.1 3279
6 EX-31.1 a2196645zex-31_1.htm EX-31.1 8167
7 EX-31.2 a2196645zex-31_2.htm EX-31.2 8209
8 EX-32 a2196645zex-32.htm EX-32 7143
9 G732445.JPG g732445.jpg GRAPHIC 79817
10 G866098.JPG g866098.jpg GRAPHIC 61325
  Complete submission text file 0001047469-10-001540.txt   1436300
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-30319 | Film No.: 10639831
SIC: 2834 Pharmaceutical Preparations